R&D capacities

    Observing cell response to oxygen depletion is crucial in oncogenic progression, tumor treatment outcomes, ischemia and various vascular diseases.

    ADELBIO is involved and supports R&D projects from pharmaceutical, biotechnological firms, and academic laboratories interested in new targeted therapies. ADELBIO represents a privileged partner to provide or co-develop these innovating tools.

    ADELBIO takes advantage of local and qualified subcontractors and develops its activities at the Center for Biomedical Research and Valorisation (CBRV) of the Clermont-Ferrand University Hospital.
   

   We have access to the following research facilities: